Shuzhen Wang
State Key Laboratory Of Natural Medicines
Nanjing, 211198, China
Nanjing, 211198, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Oxidative modification of G-quadruplex triggers CLIC4-associated mitochondrial dysfunction to promote glioblastoma progression.
Journal: Redox biology
Published: October 22, 2025
The m6A reader IGF2BP1 contributes to the activation of hepatic stellate cells through facilitating TUBB4B mRNA stabilization.
Journal: Journal of gastroenterology and hepatology
Published: August 16, 2024
Cysteine sulfenylation contributes to liver fibrosis via the regulation of EphB2-mediated signaling.
Cysteine sulfenylation contributes to liver fibrosis via the regulation of EphB2-mediated signaling.
Journal: Cell death & disease
Published: February 20, 2024
The combination of tetracyclines effectively ameliorates liver fibrosis via inhibition of EphB1/2.
Journal: International immunopharmacology
Published: October 07, 2023
Neddylation of EphB1 Regulates Its Activity and Associates with Liver Fibrosis.
Journal: International journal of molecular sciences
Published: January 09, 2023
Demethylzeylasteral attenuates hepatic stellate cell activation and liver fibrosis by inhibiting AGAP2 mediated signaling.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: January 25, 2022
MD2 Is a Potential Biomarker Associated with Immune Cell Infiltration in Gliomas.
Journal: Frontiers in oncology
Published: January 14, 2022
Synergistic antifibrotic effects of miR-451 with miR-185 partly by co-targeting EphB2 on hepatic stellate cells.
Journal: Cell death & disease
Published: January 06, 2020
Author Correction: Novel 2-phenyloxypyrimidine derivative induces apoptosis and autophagy via inhibiting PI3K pathway and activating MAPK/ERK signaling in hepatocellular carcinoma cells.
Journal: Scientific reports
Published: December 20, 2019
Bifunctional Fusion Proteins Derived from Tumstatin and 4-1BBL for Targeted Cancer Therapy.
Journal: Molecular pharmaceutics
Published: December 20, 2018
Novel 2-phenyloxypyrimidine derivative induces apoptosis and autophagy via inhibiting PI3K pathway and activating MAPK/ERK signaling in hepatocellular carcinoma cells.
Journal: Scientific reports
Published: April 23, 2018
Last Updated: 09/26/2026